Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
American Journal of Hematology|December 4, 2024
Feasibility of a Biomarker-Based Screening for Pre-Symptomatic AL Amyloidosis in Patients With Intermediate/High-Risk MGUSSilvia Mangiacavalli, Paolo Milani, Claudio Salvatore Cartia, et al.American Journal of Hematology|April 14, 2020
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltratePaolo Milani, Francesca Fazio, Marco Basset, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 11, 2011
Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosisGiovanni Palladini, Alessandra Barassi, Stefano Perlini, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 11, 2024
Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosisPaolo Milani, Francesca Fabris, Roberta Mussinelli, et al.Blood|July 21, 2010
The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosisGiovanni Palladini, Alessandra Barassi, Catherine Klersy, et al.Clinical Chemistry and Laboratory Medicine|January 12, 2022
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patientsMarco Basset, Paolo Milani, Virginia Valeria Ferretti, et al.Blood|March 13, 2013
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosisAshutosh D Wechalekar, Stefan O Schonland, Efstathios Kastritis, et al.Clinical Chemistry and Laboratory Medicine|March 27, 2017
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assaysGiovanni Palladini, Arnaud Jaccard, Paolo Milani, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 28, 2020
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosisRiccardo Caccialanza, Emanuele Cereda, Catherine Klersy, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 4, 2025
Left ventriculo-arterial coupling in a contemporary cohort of patients with wild-type transthyretin cardiac amyloidosis treated with tafamidisGiuseppe Damiano Sanna, Valeria Anna Di Simone, Paolo Milani, et al.Pageof 7